Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study

Autor: Garcia-Manero, Guillermo, Goldberg, Aaron D, Winer, Eric S, Altman, Jessica K, Fathi, Amir T, Odenike, Olatoyosi, Roboz, Gail J, Sweet, Kendra, Miller, Crystal, Wennborg, Anders, Hickman, Denice K, Kanagal-Shamanna, Rashmi, Kantarjian, Hagop, Lancet, Jeffrey, Komrokji, Rami, Attar, Eyal C, Sallman, David A *
Zdroj: In The Lancet Haematology April 2023 10(4):e272-e283
Databáze: ScienceDirect